UCHL1 anticorps (N-Term)

N° du produit ABIN544860

Détail du produit anti-UCHL1 anticorps

Antigène: UCHL1 (Ubiquitin Carboxyl-terminal Esterase L1 (Ubiquitin Thiolesterase) (UCHL1))

Épitope: N-Term

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp UCHL1 est non-conjugé

Application: Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Flow Cytometry (FACS)

Fonction: Rabbit polyclonal antibody raised against synthetic peptide of UCHL1.

Réactivité croisée: Humain, Souris

Immunogène: A synthetic peptide (conjugated with KLH) corresponding to N-terminus of human UCHL1.

Information d'application

Indications d'application: Flow Cytometry (1:10-50)
Immunofluorescence (1:10-50)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (1:10-50)
Western Blot (1:1000)
The optimal working dilution should be determined by the end user.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: In PBS (0.09 % sodium azide)

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.

Références pour anticorps anti-UCHL1 (ABIN544860)

Jin, Yu, Lou, Zhou, Han, Zhao, Lin: "UCHL1 Is a Putative Tumor Suppressor in Ovarian Cancer Cells and Contributes to Cisplatin Resistance." dans: Journal of Cancer, Vol. 4, Issue 8, pp. 662-70, (2013) (PubMed).

Nishikawa, Li, Kawamura, Osaka, Wang, Hara, Hirokawa, Manago, Amano, Noda, Aoki, Wada: "Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants." dans: Biochemical and biophysical research communications, Vol. 304, Issue 1, pp. 176-83, (2003) (PubMed).

Maraganore, de Andrade, Lesnick, Farrer, Bower, Hardy, Rocca: "Complex interactions in Parkinson's disease: a two-phased approach." dans: Movement disorders : official journal of the Movement Disorder Society, Vol. 18, Issue 6, pp. 631-6, (2003) (PubMed).

Liu, Fallon, Lashuel, Liu, Lansbury: "The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility." dans: Cell, Vol. 111, Issue 2, pp. 209-18, (2002) (PubMed).

Détails sur UCHL1

Antigène: UCHL1 (Ubiquitin Carboxyl-terminal Esterase L1 (Ubiquitin Thiolesterase) (UCHL1))

Autre désignation: UCHL1 / PGP9.5 (UCHL1 Produits)

Synonymes: anticorps PARK5, anticorps PGP 9.5, anticorps PGP9.5, anticorps PGP95, anticorps Uch-L1, anticorps UCH-L1, anticorps UCHL1, anticorps cb358, anticorps wu:fc55h08, anticorps park5, anticorps pgp9.5, anticorps uch-l1, anticorps MGC132191, anticorps uchl1, anticorps AW822034, anticorps C88048, anticorps R75593, anticorps UCHL-1, anticorps gad, anticorps ubiquitin C-terminal hydrolase L1, anticorps ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase), anticorps ubiquitin C-terminal hydrolase L1 L homeolog, anticorps ubiquitin carboxyl-terminal esterase L1, anticorps ubiquitin carboxy-terminal hydrolase L1, anticorps UCHL1, anticorps uchl1, anticorps uchl1.L, anticorps LOC100304750, anticorps Uchl1

ID gène: 7345

Pathways: Feeding Behaviour